Venture Funding Deals: Sumitomo Alliance With Roivant Takes Shape
Broad Alliance Includes $550m In Loans To 'Vants'
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced October to November.
